5 Stocks Insiders are Buying Now

2. Harrow Health, Inc. (NASDAQ:HROW)

Number of Hedge Fund Holders: 13

Harrow Health, Inc. (NASDAQ:HROW) is a leading healthcare company with a dedicated focus on ophthalmic diseases. The company was founded in 1998 and is headquartered in Nashville, Tennessee. Insiders are racking up shares of Harrow Health, Inc. (NASDAQ:HROW). On December 14, the company disclosed in a regulatory filing that major shareholder Opaleye Management purchased 431,183 common shares at $10.52 per share. The transaction was valued at $4.53 million.

On October 3, Lake Street analyst Brooks O’Neil maintained a Buy rating and his $17 price target on Harrow Health, Inc. (NASDAQ:HROW).

At the close of the third quarter of 2022, 13 hedge funds were eager on Harrow Health, Inc. (NASDAQ:HROW) and held stakes of $87.1 million in the company. This is compared to 13 hedge funds in the previous quarter with stakes of $78.2 million.

Here is what SRK Capital had to say about Harrow Health, Inc. (NASDAQ:HROW) in its second-quarter 2022 investor letter:

“I have written about Harrow Health in my previous two letters to you, but I find it necessary to continue to explain my thought process in order to convey my conviction in the company. During periods of negative performance, I believe it is more vital than ever that our partners understand my thought process in order for you to adequately discern what it is that I do as your manager. HROW is our largest position, our largest detractor year to date, and the opportunity I am most excited about over the next six months.

Harrow Health is an ophthalmology focused healthcare company. The core business, ImprimisRx, is a compounding pharmacy that customizes medications to the needs of eye care physicians and their patients. It is estimated that north of 90% of ophthalmologists and optometrists use compounded formulations in their practice. Physicians choose to work with ImprimisRx because they are the largest and most trusted compounding pharmacy in the eye care market and have achieved this by solving pain points for physicians and their patients, where others could not satisfy their needs…” (Click here to see the full text)